Lead Sponsor

Washington University School of Medicine

Collaborators

Age

18 - No limit years

Sex

FEMALE

Healthy Volunteers

No

•Diagnosis of breast cancer, any subtype, stage I-III, within the last 36 months, who have completed primary therapy of their breast cancer (surgery, radiation, and chemotherapy). Must be at least 4 weeks post their last chemotherapy or radiation therapy. Concurrent hormonal therapy is allowed.
•At least 18 years of age.
•Determined to have a high AGE diet at baseline (dietary AGE intake greater than 14 Eq/day as assessed by food frequency questionnaire).
•Ability to understand and willingness to sign an IRB approved written informed consent document.

•Diagnosis of diabetes.
•History of eating disorder or body dysmorphic disorder.
•Active tobacco use (tobacco is a source of advanced glycation end products).
•Active participation in other dietary or physical activity clinical trials or community interventions.
•Taking and unwilling/unable to stop taking B-6 (pyridoxamine), B1 (thiamine) or metformin (all known AGE inhibitors).

Related studies

NCT07586215 · Breast Cancer Metastatic

NCT05831878 · Advanced Breast Cancer

NCT07578064 · Breast Cancer, Bone Marrow Suppression

NCT07368998 · Breast Cancer

NCT06525766 · Anatomic Stage IV Breast Cancer AJCC v8, Estrogen-receptor-positive Breast Cancer, and more

A Low AGE (Advanced Glycation End-product) Dietary Intervention for Breast Cancer Survivors